Clinical Trials
Here at the USC Roski Eye Institute, we offer patients the opportunity to participate in clinical trials and research. Please see our active clinical trials below. Contact our clinical trial navigators for opportunities that may be suitable for you.
| Protocol Name | Study Title | Link to Clinical Trials |
|---|---|---|
| HZNP-TEP-402 | A Phase 3b/4, Double-masked, Randomized, International, Parallel-assignment, Multicenter Trial in Patients with Thyroid Eye Disease to Evaluate the Safety and Tolerability of Different Dosing Durations of Teprotumumab | https://clinicaltrials.gov/ct2/show/NCT05002998 |
| VRDN-001-101 | A multiple ascending dose (MAD) safety, tolerability and efficacy study of VRDN-001, a humanized monoclonal antibody directed against the IGF-1 receptor, in normal healthy volunteers (NHVs) and subjects with thyroid eye disease (TED) | https://clinicaltrials.gov/ct2/show/NCT05176639 |
| ACELYRIN-21103 | A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Non-infectious, Intermediate-, Posterior- or Pan-uveitis | https://clinicaltrials.gov/ct2/show/NCT05384249 |
| OTX-TIC-2020-201 | A prospective, multi-center, randomized, parallel-group, controlled study to evaluate the efficacy and safety of OTX-TIC (travoprost) intracameral implant in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT) | https://clinicaltrials.gov/ct2/show/NCT05335122 |
Contact Information:
Research Coordinator: Seong Shin
P: 323-442-6490
E: seong.shin@med.usc.edu